Solid Phase Extraction Market Size

Solid Phase Extraction Market size was USD 354.9 million in 2024 and is estimated to reach USD 621.1 million by the end of 2037, expanding at a CAGR of 4.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of solid phase extractions is assessed at USD 370.5 million.

The rapidly expanding pharmaceutical and biotechnology sectors are offering lucrative opportunities for solid phase extraction solution producers. The need for purity and consistency in drug production and molecular biology and rising regulatory demands for product testing are set to augment the adoption of solid phase extraction technologies. For instance, the global pharmaceutical market was evaluated at USD 1.6 trillion in 2023. Pharma companies headquartered in New Brunswick and New Jersey totaled revenues of around USD 85.0 billion. Johnson & Johnson is the pharmaceutical leader across the world followed by Pfizer, Merck & Co., and AbbVie. North America and Europe followed by Asia Pacific are leading the future of the pharma and biopharma sectors.

Furthermore, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reveals that the biopharmaceutical sector is anticipated to witness a rise in R&D sending from USD 179.0 billion in 2020 to USD 213.0 billion by 2026. The Research Nester’s analysis estimates that in 2024, the revenues from biotech drug sales totaled USD 436.0 billion, particularly in North America and Europe. The global sales of biotech drugs were calculated at USD 458.0 billion in 2024. Thus, continuous investments in drug research and development are directly augmenting the demand for solid phase extraction technologies and consumables.